Seronegative West Nile Virus Infection in a Patient Treated with Rituximab for Rheumatoid Arthritis

Am J Med. 2017 Jun;130(6):e257-e258. doi: 10.1016/j.amjmed.2017.01.014. Epub 2017 Feb 3.

Authors

Chris Goates¹, Sanefumi Tsuha², Selene Working², Jessica Carey³, Emily S Spivak⁴

Affiliations

¹ Texas A&M College of Medicine, College Station.
² Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City.
³ Department of Pharmacy, University of Utah Healthcare, Salt Lake City.
⁴ Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City. Electronic address: emily.spivak@hsc.utah.edu.

PMID: 28163051
DOI: 10.1016/j.amjmed.2017.01.014

No abstract available

Publication types

Case Reports

MeSH terms

Antirheumatic Agents / adverse effects*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / drug therapy*
Fatal Outcome
Female
Humans
Immunocompromised Host*
Meningoencephalitis / blood
Meningoencephalitis / diagnosis*
Meningoencephalitis / immunology
Middle Aged
Rituximab / adverse effects*
Rituximab / therapeutic use
West Nile Fever / blood
West Nile Fever / diagnosis*
West Nile Fever / immunology

Substances

Antirheumatic Agents
Rituximab